Design, crystal structure and anticancer activities of a novel bimetallic organotin and copper(I) cyanide with dipyridyl ketone supramolecular coordination polymer

Puntos clave

• The novel bimetallic organotin and copper(I) cyanide compound exhibit notable anticancer activities against several cancer cell lines.
• Key evidence showed maximum inhibition rates of over 70% on specific cancer cells identified during the analysis.
• Analysis of the crystal structure demonstrates the unique supramolecular organization of the compound, enhancing its efficacy.
• Findings highlight the potential of this compound in cancer treatment, requiring further evaluation in clinical settings.